![Dirk Huebner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Huebner
Directeur Technique/Scientifique/R&D chez
APTEVO THERAPEUTICS INC.
Fortune : 1 176 $ au 31/08/2026
Profil
Dirk Huebner is Chief Medical Officer & Senior Vice President at Aptevo Therapeutics, Inc. since 2025.
Formerly, Dr. Huebner was Executive Medical Director at Millennium Pharmaceuticals, Inc. in 2017, Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020, and Vice President at Boston Biomedical, Inc. from 2017 to 2018.
Education includes a doctorate from Freie Universität Berlin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/08/2026 | 482 ( 0,03 % ) | 1 176 $ | 31/08/2026 |
Postes actifs de Dirk Huebner
| Sociétés | Poste | Début |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/04/2022 |
Anciens postes connus de Dirk Huebner
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur Technique/Scientifique/R&D | 30/11/2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Corporate Officer/Principal | 01/11/2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/08/2017 |
Formation de Dirk Huebner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
